Budesonide for induction of remission in Crohn's disease
about
Update on autoimmune hepatitisBudesonide for maintenance of remission in Crohn's diseaseHelminth therapy (worms) for induction of remission in inflammatory bowel diseaseHelminths for induction of remission in inflammatory bowel diseaseOral budesonide for induction of remission in ulcerative colitisSargramostim (GM-CSF) for induction of remission in Crohn's diseaseSargramostim (GM-CSF) for induction of remission in Crohn's diseaseOral budesonide for induction of remission in ulcerative colitisBudesonide for maintenance of remission in Crohn's diseasePharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsCrohn's disease: a clinical updateEvidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in JapanTherapeutic benefits of budesonide in gastroenterologyManagement of active Crohn disease.Practical medical management of Crohn's disease.Treatment of eosinophilic esophagitis: is oral viscous budesonide superior to swallowed fluticasone spray?Role of conventional therapies in the era of biological treatment in Crohn's disease.Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticlesGlucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity.If it walks like Crohn's and talks like Crohn's, it must be...The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?Tranexamic Acid and Supportive Measures to Treat Wasting Marmoset Syndrome.Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.Second Korean guidelines for the management of Crohn's disease.Consensus guidelines for the management of inflammatory bowel disease.Medical management of crohn disease.Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.Dexamethasone-pDMAEMA polymeric conjugates reduce inflammatory biomarkers in human intestinal epithelial monolayers.Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.
P2860
Q22305505-78F3AFB0-61D3-4772-971B-A1D0AAB7FA50Q24194313-4E354320-FCB3-4644-AC02-A7A53B31D09FQ24201067-F4FA27E7-1C65-4DFD-8E67-300E6E3D1E2FQ24234013-C784A043-1904-4AAD-BD79-E4FD2BC18005Q24234633-C7ADC929-24E6-4225-8F99-59FF65F7D508Q24235068-16C1EFDF-260B-45F1-B739-005944281398Q24235115-5DE1C7EB-AFB2-4EAE-8B4F-F5CF369B2C3CQ24240602-CC77117D-2251-46D9-8768-A0FB1CAB9668Q24241252-2D5F18F4-416D-4A49-9D43-FD62DB524775Q26768280-8774D22C-C563-4B62-A41B-7DF8C3669EA8Q26777696-F79E28BC-F195-464C-9EDF-CBD138BE5ECBQ26829392-114F0E96-B41C-4884-954D-E57448B0CC9CQ28281682-E5D92711-1D67-4F30-BD45-DEF3D1C1468CQ34345967-2657B00A-EAC0-4E34-8F42-DF9AECAF95E3Q34389885-D01E045F-0BA1-4769-ABF4-4282F90E43AAQ34571174-2E9A6317-C354-4CED-96A3-DAEBFFBECF24Q34831072-54BC8597-DA67-4EDF-B31B-B66DE841BD50Q35871764-8EA42767-D4E6-4C99-9E3A-E163C0B5EA12Q36659176-EF4A3BDB-04A4-4846-A843-8C74BFCE4658Q36704021-50EB8F56-6BA8-40EA-865E-6F84D1B9FC5BQ37277894-E5C31DD8-E155-4FE5-91E2-7D6BA29DC05FQ37505888-205B4F31-6AF0-48A1-98B8-A5F57727394CQ37600339-255FBFC8-8D38-4B2D-B2D7-5D941671E2AEQ37662498-1A1AD42C-EF54-4740-A455-7A91C1AE6296Q37817803-8A6FC334-DDB3-4912-8FFB-CB8746585D06Q38179378-EB7D15FC-5BEB-43E5-802F-0C16145ADECCQ38394726-ACC4AE2D-3935-435A-A0FE-95C36FA07654Q38408897-9A19915B-C38C-4850-AD72-DA26D78FB51FQ40383123-CB7417E5-F05D-4412-9857-23773BF0D70EQ42877648-10160673-495F-426A-B399-9CA201A98238
P2860
Budesonide for induction of remission in Crohn's disease
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Budesonide for induction of remission in Crohn's disease
@ast
Budesonide for induction of remission in Crohn's disease
@en
Budesonide for induction of remission in Crohn's disease
@en-gb
Budesonide for induction of remission in Crohn's disease
@nl
type
label
Budesonide for induction of remission in Crohn's disease
@ast
Budesonide for induction of remission in Crohn's disease
@en
Budesonide for induction of remission in Crohn's disease
@en-gb
Budesonide for induction of remission in Crohn's disease
@nl
prefLabel
Budesonide for induction of remission in Crohn's disease
@ast
Budesonide for induction of remission in Crohn's disease
@en
Budesonide for induction of remission in Crohn's disease
@en-gb
Budesonide for induction of remission in Crohn's disease
@nl
P2093
P2860
P1476
Budesonide for induction of remission in Crohn's disease
@en
P2093
A Hillary Steinhart
Anne Marie Griffiths
Anthony R Otley
Cynthia H Seow
P2860
P356
10.1002/14651858.CD000296.PUB3
P577
2008-07-16T00:00:00Z